MacroGenics to Participate in the Stifel 2025 Healthcare Conference

Rhea-AI Summary

MacroGenics (Nasdaq: MGNX) announced that President and CEO Eric Risser will participate in a fireside chat at the Stifel 2025 Healthcare Conference on Thursday, November 13, 2025 at 4:00 PM ET in New York.

A live webcast will be available via the company's Investor Relations "Events & Presentations" page and an archived replay will be maintained on the website for 30 days.

News Market Reaction – MGNX

+0.74%

+0.74% Session close to close

In the Nov 7 session, MGNX gained 0.74%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ROCKVILLE, MD, Nov. 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Eric Risser, President and CEO of MacroGenics, will participate in a fireside chat at the Stifel 2025 Healthcare Conference on Thursday, November 13, 2025, at 4:00 pm ET in New York, NY.

A webcast of the presentation may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics' website at http://ir.macrogenics.com/events.cfm. The Company will maintain an archived replay of the webcast on its website for 30 days.

About MacroGenics, Inc.

MacroGenics (the Company) is a biopharmaceutical company focused on developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company's website at www.macrogenics.com. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.

Contacts:
Jim Karrels, Senior Vice President, CFO
1-301-251-5172
info@macrogenics.com 

Argot Partners
1-212-600-1902
macrogenics@argotpartners.com 

FAQ

When will MacroGenics (MGNX) present at the Stifel 2025 Healthcare Conference?

MacroGenics (MGNX) will present on Thursday, November 13, 2025 at 4:00 PM ET.

Who from MacroGenics (MGNX) will speak at the Stifel 2025 Healthcare Conference?

Eric Risser, President and CEO of MacroGenics, will participate in a fireside chat.

Where can investors watch the MacroGenics (MGNX) webcast for the Stifel 2025 Healthcare Conference?

The live webcast and archived replay will be available under Investor Relations > Events & Presentations on the company's website.

How long will the MacroGenics (MGNX) replay remain available after the Stifel 2025 Healthcare Conference?

The company will maintain an archived replay on its website for 30 days.

Is the MacroGenics (MGNX) presentation at Stifel 2025 available on demand for international investors?

Yes; the presentation will be webcast and an archived replay will be available on the Investor Relations site for 30 days, allowing on-demand viewing.